{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:01:37Z","timestamp":1776258097783,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ccl.2013.09.003","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:46:15Z","timestamp":1385426775000},"page":"63-71","source":"Crossref","is-referenced-by-count":9,"title":["Management of ACCF\/AHA Stage A and B Patients"],"prefix":"10.1016","volume":"32","author":[{"given":"Faiz","family":"Subzposh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley R.","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard J.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2013.09.003_bib1","series-title":"2010 heart and stroke statistical update","author":"American Heart Association","year":"2010"},{"issue":"18","key":"10.1016\/j.ccl.2013.09.003_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib3","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","article-title":"Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community","volume":"115","author":"Ammar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib5","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib6","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for\u00a0congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1071-9164(97)90022-1","article-title":"The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease","volume":"3","author":"Kjekshus","year":"1997","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.ccl.2013.09.003_bib8","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000054165.93055.42","article-title":"Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study","volume":"107","author":"Arnold","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.003_bib12","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccl.2013.09.003_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.1997.03540330061036","article-title":"Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis","volume":"277","author":"Psaty","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.003_bib14","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.003_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.003_bib16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"19","key":"10.1016\/j.ccl.2013.09.003_bib17","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease: the Framingham Study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.003_bib18","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.165.12.1401","article-title":"Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"165","author":"Whelton","year":"2005","journal-title":"Arch Intern Med"},{"issue":"Suppl I","key":"10.1016\/j.ccl.2013.09.003_bib19","first-page":"721","article-title":"Diabetes predicts congestive heart failure risk in the elderly","volume":"98","author":"Chae","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ahj.2007.12.023","article-title":"Differential effects of lipids on the risk of heart failure and coronary artery disease: the Physicians Health Study","volume":"155","author":"Dhingra","year":"2008","journal-title":"Am Heart J"},{"issue":"25","key":"10.1016\/j.ccl.2013.09.003_bib21","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/hrt.2006.089011","article-title":"Metabolic syndrome and risk for heart failure in middle-aged men","volume":"92","author":"Ingelsson","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2013.09.003_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCHEARTFAILURE.112.000054","article-title":"Physical fitness and risk for heart failure and coronary artery disease","volume":"6","author":"Berry","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ccl.2013.09.003_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMcp022709","article-title":"Diastolic heart failure","volume":"351","author":"Aurigemma","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","article-title":"Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study","volume":"163","author":"Shahar","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2010.08.627","article-title":"Obstructive sleep apnea and heart failure","volume":"57","author":"Kasai","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.003_bib28","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1053\/ajkd.2001.28588","article-title":"A\u00a0cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients","volume":"38","author":"Stack","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2013.09.003_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00041552-200411000-00003","article-title":"Cardiovascular disease in chronic kidney disease from a cardiologist\u2019s perspective","volume":"13","author":"McCullough","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ccl.2013.09.003_bib30","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","author":"K\/DOQI Workgroup","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2013.09.003_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/17.4.645","article-title":"Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients","volume":"17","author":"DeLima","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ccl.2013.09.003_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diacare.26.3.855","article-title":"Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABete, Hypertension, Cardiovascular Events and Ramipril) study","volume":"26","author":"Vaur","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ccl.2013.09.003_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/oxfordjournals.eurheartj.a059542","article-title":"Risk factors for heart failure in the general population: the study of men born in 1913","volume":"10","author":"Eriksson","year":"1989","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2013.09.003_bib34","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0735-1097(01)01195-0","article-title":"Relationship of\u00a0current and past smoking to mortality and morbidity in patients with left ventricular dysfunction","volume":"37","author":"Suskin","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.003_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-136-3-200202050-00005","article-title":"Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study","volume":"136","author":"Walsh","year":"2002","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.ccl.2013.09.003_bib36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cardfail.2011.05.008","article-title":"Alcoholic cardiomyopathy: a review","volume":"17","author":"George","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.ccl.2013.09.003_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jama.1990.03450030101041","article-title":"Alcohol and the cardiovascular system","volume":"264","author":"Regan","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.003_bib38","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.jacc.2012.07.068","article-title":"Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"60","author":"Chen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.003_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002018-200831060-00002","article-title":"Cardiotoxicity profile of trastuzumab","volume":"31","author":"Ewer","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.ccl.2013.09.003_bib40","article-title":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology","year":"2013","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ccl.2013.09.003_bib41","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","author":"Kerkela","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05759.x","article-title":"Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies","volume":"131","author":"Wouters","year":"2005","journal-title":"Br\u00a0J Haematol"},{"key":"10.1016\/j.ccl.2013.09.003_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/clc.4960130505","article-title":"Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population","volume":"13","author":"Bertolet","year":"1990","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2013.09.003_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pcad.2009.11.004","article-title":"Alcoholic and cocaine-associated cardiomyopathies","volume":"52","author":"Awtry","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ccl.2013.09.003_bib45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1540-8167.2005.50038.x","article-title":"The clinical implications of cumulative right ventricular pacing in the Multicenter Automatic Defibrillator Trial II","volume":"16","author":"Steinberg","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ccl.2013.09.003_bib46","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa0907555","article-title":"Biventricular pacing in patients with bradycardia and normal ejection fraction","volume":"361","author":"Yu","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccl.2013.09.003_bib47","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1540-8159.2005.00143.x","article-title":"Tachycardia-induced cardiomyopathy: a review of literature","volume":"28","author":"Khasnis","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"issue":"7","key":"10.1016\/j.ccl.2013.09.003_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.hrthm.2010.03.036","article-title":"Relationship between burden of premature ventricular complexes and left ventricular function","volume":"7","author":"Baman","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccl.2013.09.003_bib49","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.102.13.1542","article-title":"Cardiac dysfunction and mortality in HIV-infected children: the prospective P2C2 HIV multicenter study. Pediatric pulmonary and cardiac complications of vertically transmitted HIV infection (P2C2 HIV) study group","volume":"102","author":"Lipshultz","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib50","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.296.7.844","article-title":"Metabolic and skeletal complications of HIV infection: the price of success","volume":"296","author":"Morse","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ccl.2013.09.003_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ahj.2005.06.012","article-title":"Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV multicenter study","volume":"150","author":"Fisher","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2013.09.003_bib52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1749-6632.2001.tb03916.x","article-title":"Cardiovascular monitoring and therapy for HIV-infected patients","volume":"946","author":"Lipshultz","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ccl.2013.09.003_bib53","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib54","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.echo.2010.06.017","article-title":"The incremental prognostic value of echocardiography in asymptomatic stage A heart failure","volume":"23","author":"Carerj","year":"2010","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.ccl.2013.09.003_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2003.10.043","article-title":"Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction","volume":"43","author":"Heidenreich","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.003_bib56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0002-9149(02)03335-0","article-title":"Prevention and management of chronic heart failure in management of asymptomatic patients","volume":"9","author":"Frigerio","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2013.09.003_bib57","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/CIRCULATIONAHA.105.600437","article-title":"Stage B heart failure management of asymptomatic left ventricular systolic dysfunction","volume":"24","author":"Goldberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib58","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"8","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib59","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"12","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community","volume":"2","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.003_bib61","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0735-1097(01)01110-X","article-title":"Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study","volume":"4","author":"Aurigemma","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.003_bib62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.hfc.2011.11.007","article-title":"Clinical monitoring of stage B heart failure: echocardiography","volume":"2","author":"Coglianese","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.ccl.2013.09.003_bib63","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"5","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.106.666016","article-title":"Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial","volume":"1","author":"Colucci","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib65","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after\u00a0myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.003_bib66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000108928.25690.94","article-title":"Effects of carvedilol on left ventricular remodelling in patients following acute myocardial infarction: the CAPRICORN echo substudy","volume":"2","author":"Doughty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.003_bib67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.hfc.2011.11.006","article-title":"The role of renin angiotensin system intervention in stage B heart failure","volume":"2","author":"Collier","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.ccl.2013.09.003_bib68","first-page":"685","article-title":"Effect of enalapril on mortality and the development of heart-failure in asymptomatic patients with reduced left-ventricular ejection fractions","volume":"10","author":"Nicklas","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib69","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.003_bib70","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"20","author":"Pfeffer","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib71","first-page":"385","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction. Multicenter Diltiazem Postinfarction Trial Research Group","volume":"7","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Trial","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"10","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib74","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"14","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib75","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2009.08.021","article-title":"Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone","volume":"18","author":"Mak","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.003_bib76","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"12","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib77","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"21","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.003_bib78","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2006.05.021","volume":"3","author":"Bonow","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865113000866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865113000866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T22:28:12Z","timestamp":1564871292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865113000866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0733865113000866"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2013.09.003","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}